Media

The Biotechnology Innovation Organization (BIO) is pleased to announce that the Honorable Dennis McGinn, Assistant Secretary of the Navy, Energy, Installations...
BIO Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s proposed Part B Drug Payment Model and...

Press Releases

Oct 1 2002
8:30 - 8:45 a.m.RALSTON BALLROOM Welcoming RemarksCarl B. Feldbaum, president, Biotechnology Industry Organization   8:45 - 10:15 a.m.OPENING...
Sep 25 2002
WASHINGTON, D.C. (September 25, 2002) – Biotechnology Industry Organization (BIO) President Carl B. Feldbaum today issued the following statement regarding...
Sep 18 2002
Washington, D.C. (September 18, 2002) - The Biotechnology Industry Organization (BIO) today released a list of 131 biotechnology companies chosen to present at...
Sep 12 2002
Washington, D.C. (September 12, 2002) – The Biotechnology Industry Organization (BIO) will host its second annual BIO VentureForum on Oct. 1-2, in San...
Sep 6 2002
In response to the FDA’s plan to consolidate reviews of pharmaceutical products, including biologics, at the Center for Drug Evaluation and Research, BIO...
Aug 12 2002
WASHINGTON, D.C. (August 12, 2002) – Biotechnology Industry Organization (BIO) Vice President for Bioethics Michael Werner issued the following statement...
Aug 1 2002
Washington, D.C. (August 1, 2002) – Dr. Michael J. Phillips, Executive Director of Food and Agriculture of the Biotechnology Industry Organization (BIO),...
Jul 31 2002
WASHINGTON, D.C. (July 31, 2002) - Biotechnology Industry Organization (BIO) President Carl B. Feldbaum issued the following statement regarding today’s...
Jul 23 2002
WASHINGTON, D.C. (July 23, 2002) - Biotechnology Industry Organization Vice President for Government Relations Sharon L. Cohen called the Senate’s lack of...